Drug approvals speed up by 20% under new FDA leadership by Q1 2027

Regardless of Makary's fate, the FDA enacts policies under new leadership that accelerate drug approvals by reducing clinical trial burdens or streamlining review processes for priority drugs.

Implied probability (Yes)

55%

Closes

2027-12-31